Home › NDC Lookup › RxCUI directory › RxCUI 2632729

2 ML emicizumab-kxwh 150 MG/ML Injection [Hemlibra] — RxCUI 2632729

Name: 2 ML emicizumab-kxwh 150 MG/ML Injection [Hemlibra] (RxCUI 2632729)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2632729 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2632729

Official name2 ML emicizumab-kxwh 150 MG/ML Injection [Hemlibra]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as2 ML Hemlibra 150 MG/ML Injection; Hemlibra 300 MG in 2 ML Injection; Hemlibra 300 MG per 2 ML Injection

FDA products mapped6

Package NDCs mapped6

Reported Medicaid activity (SDUD)27,047 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Emicizumab: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's not the same, but it does a similar job. In hemophilia A, your body is missing factor VIII, a protein that helps blood clot by linking two other proteins together. Hemlibra is...
What exactly does Hemlibra do — is it the same as taking factor VIII?
After starting with weekly injections for the first four weeks to build up levels quickly, you'll switch to a maintenance schedule — either weekly, every two weeks, or every four w...
How often do I need to inject myself, and can I do it at home?

📖 Read our full Emicizumab guide →

🕸️ Concept Web — How 2 ML emicizumab-kxwh 150 MG/ML Injection [Hemlib... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML emicizumab-kxwh 150 MG/ML Injection [Hemlibra] RxCUI 2632729 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Emicizumab 1989794 IN
- Emicizumab-kxwh 1989795 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Hemlibra 1989800 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Emicizumab Injection 1989798 SCDF
- Emicizumab-kxwh Injection 2647667 SCDFP
- Emicizumab Injectable Product 1989797 SCDG
- Emicizumab-kxwh Injectable Product 2662721 SCDGP
- Emicizumab Injection [Hemlibra] 1989802 SBDF
- Emicizumab-kxwh Injection [Hemlibra] 2657913 SBDFP
- Hemlibra Injectable Product 1989803 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 2 ML emicizumab-kxwh 150 MG/ML Injection 2632728 SCD
- Emicizumab-kxwh 150 MG/ML 1989808 SCDC
- Emicizumab-kxwh 150 MG/ML [Hemlibra] 1989810 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

2 ML emicizumab-kxwh 150 MG/ML Injection SCD · 2632728
Emicizumab-kxwh 150 MG/ML SCDC · 1989808
Emicizumab Injection SCDF · 1989798
Emicizumab-kxwh Injection SCDFP · 2647667
Emicizumab Injectable Product SCDG · 1989797
Emicizumab-kxwh Injectable Product SCDGP · 2662721

Brand-Name Concepts

Emicizumab-kxwh 150 MG/ML [Hemlibra] SBDC · 1989810
Emicizumab Injection [Hemlibra] SBDF · 1989802
Emicizumab-kxwh Injection [Hemlibra] SBDFP · 2657913
Hemlibra Injectable Product SBDG · 1989803
Hemlibra BN · 1989800

📦 FDA Products & Package NDCs

6 products · 6 package NDCs

6 package NDCs map to RxCUI 2632729 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50242-0920-01	1 VIAL, SINGLE-USE in 1 CARTON (50242-920-01) / 1 mL in 1 V...	Hemlibra	Genentech, Inc.	2017-11-16
50242-0921-01	1 VIAL, SINGLE-USE in 1 CARTON (50242-921-01) / .4 mL in 1...	Hemlibra	Genentech, Inc.	2017-11-16
50242-0922-01	1 VIAL, SINGLE-USE in 1 CARTON (50242-922-01) / .7 mL in 1...	Hemlibra	Genentech, Inc.	2017-11-16
50242-0923-01	1 VIAL, SINGLE-USE in 1 CARTON (50242-923-01) / 1 mL in 1 V...	Hemlibra	Genentech, Inc.	2017-11-16
50242-0927-01	1 VIAL, SINGLE-USE in 1 CARTON (50242-927-01) / .4 mL in 1...	Hemlibra	Genentech, Inc.	2024-01-31
50242-0930-01	1 VIAL, SINGLE-USE in 1 CARTON (50242-930-01) / 2 mL in 1 V...	Hemlibra	Genentech, Inc.	2023-03-16

Observed labelers: Genentech, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J7170	Inj., emicizumab-kxwh 0.5 mg	6	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.